Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma

被引:65
|
作者
Sahlmann, Carsten-Oliver [1 ]
Meller, Birgit [1 ]
Bouter, Caroline [1 ]
Ritter, Christian Oliver [2 ]
Stroebel, Philipp [4 ]
Lotz, Joachim [2 ]
Trojan, Lutz [3 ]
Meller, Johannes [1 ]
Hijazi, Sameh [3 ]
机构
[1] Univ Med Ctr Goettingen, Dept Nucl Med, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Univ Med Ctr Goettingen, Dept Diagnost & Intervent Radiol, D-37075 Gottingen, Germany
[3] Univ Med Ctr Goettingen, Dept Urol, D-37075 Gottingen, Germany
[4] Univ Med Ctr Goettingen, Dept Pathol, D-37075 Gottingen, Germany
关键词
Prostate carcinoma; PSMA; HBED; PET; PET/CT; 68Ga; DUAL-TIME-POINT; GA-68-LABELED PSMA LIGAND; BIOCHEMICAL RECURRENCE; PET; DIAGNOSIS; IMPACT;
D O I
10.1007/s00259-015-3251-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Binding of Ga-68-PSMA-HBED-CC (Ga-68-PSMA) at prostate cancer (PC) cells increases over time. A biphasic protocol may help separating benign from tumor lesions. The aim of this study was the retrospective evaluation of a diagnostic incremental value of a dual-time point (biphasic) Ga-68-PSMA-PET/CT in patients with prostate cancer. Methods Retrospective analysis of 35 consecutive patients (49-78 years, median 71) with newly diagnosed PC (12/35) or recurrence of PC (23/35). PET/CT (Gemini TF16, Philips) was acquired 1 h and 3 h p. i. of 140-392 MBq (300 MBq median) Ga-68-PSMA, followed by a diagnostic contrast CT. PET findings were correlated with histology or unequivocal CT findings. Semiquantitative PET data (SUVmax, SUV mean) were acquired and target-to-background-ratios (T/B-ratio) were calculated for benign and malign lesions for both time points. Size of lymph nodes (LN) on diagnostic CT was recorded. Statistical analysis was performed for assessment of significant changes of semiquantitative PET-parameters over time and for correlation of size and uptake of lymph nodes. Results One hundred and four lesions were evaluated. Sixty lesions were referenced by histology or unequivocal CT findings, including eight (13.3 %) histopathologically benign lymph nodes, 12 (20 %) histopathologically lymph node metastases, 12 (20 %) primary tumors, three (5 %) local recurrences, and 25 (41.7 %) bone metastases. Forty-four lesions were axillary LN with normal CT-appearance. Benign lesions had significantly lower SUVmax and T/B-ratios compared with malignant findings. Malign lesions showed a significant increase of both parameters over time compared to benign findings. There was no correlation between LN size and SUVmax. The sensitivity, specificity, the positive predictive value and negative predictive value of PET/CT regarding pelvic LN was 94 %, 99 %, 89 %, and 99.5 %, respectively. Conclusions In contrast to benign tissues, the uptake of proven tumor lesions increases on Ga-68-PSMA-PET/CT over time. A biphasic PET-study may lead to a better detection of tumor lesions in unequivocal findings.
引用
收藏
页码:898 / 905
页数:8
相关论文
共 50 条
  • [21] Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    Ali Afshar-Oromieh
    Tim Holland-Letz
    Frederik L. Giesel
    Clemens Kratochwil
    Walter Mier
    Sabine Haufe
    Nils Debus
    Matthias Eder
    Michael Eisenhut
    Martin Schäfer
    Oliver Neels
    Markus Hohenfellner
    Klaus Kopka
    Hans-Ulrich Kauczor
    Jürgen Debus
    Uwe Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1781 - 1781
  • [22] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    Afshar-Oromieh, Ali
    Avtzi, Eleni
    Giesel, Frederik L.
    Holland-Letz, Tim
    Linhart, Heinz G.
    Eder, Matthias
    Eisenhut, Michael
    Boxler, Silvan
    Hadaschik, Boris A.
    Kratochwil, Clemens
    Weichert, Wilko
    Kopka, Klaus
    Debus, Juergen
    Haberkorn, Uwe
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 197 - 209
  • [23] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    Ali Afshar-Oromieh
    Eleni Avtzi
    Frederik L. Giesel
    Tim Holland-Letz
    Heinz G. Linhart
    Matthias Eder
    Michael Eisenhut
    Silvan Boxler
    Boris A. Hadaschik
    Clemens Kratochwil
    Wilko Weichert
    Klaus Kopka
    Jürgen Debus
    Uwe Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 197 - 209
  • [24] Schwannoma Showing Avid Uptake on 68Ga-PSMA-HBED-CC PET/CT
    Kanthan, Gowri L.
    Izard, Michael A.
    Emmett, Louise
    Hsiao, Edward
    Schembri, Geoffrey Paul
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : 703 - 704
  • [25] Incidental Detection of Hypothyroidism on 68Ga-PSMA-HBED-CC PET/CT Imaging
    Sood, Apurva
    Vadi, Shelvin Kumar
    Kumar, Rajender
    Singh, Harmandeep
    Mittal, Bhagwant Rai
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) : E217 - E218
  • [26] 68Ga-HBED PSMA PET/CT IN THE INITIAL STAGING OF PROSTATE CANCER
    Nadebaum, D.
    Grummet, J.
    Beech, P.
    Barber, T.
    Yap, K.
    Cherk, M.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 20 - 20
  • [27] Comparative Evaluation of ( 18 F)AlF-PSMA-HBED-CC and 68 Ga-PSMA-HBED-CC in Staging Intermediate-/High-Risk Prostate Cancer: A Prospective Study
    Loureiro, Gerardo Gabriel dos Santos
    Couto, Pablo Duarte
    Gonzalez, Juan Pablo Gambini
    Nunez, Omar Alonso
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2025,
  • [28] 68Ga-PSMA PET-CT in patients with newly diagnosed high-risk prostate cancer
    Koulikov, Victoria
    Barnes, Sophie
    Even-Sapir, Einat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [29] Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer
    Rauscher, Isabel
    Maurer, Tobias
    Souvatzoglou, Michael
    Beer, Ambros J.
    Vag, Tibor
    Wirtz, Martina
    Weirich, Gregor
    Wester, Hans-Juergen
    Gschwend, Juergen E.
    Schwaiger, Markus
    Schottelius, Margret
    Eiber, Matthias
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : E397 - E402
  • [30] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102